SCOPUS 정보 검색 플랫폼

Experimental Biology and Medicine

Volumn 231, Issue 5, 2006, Pages 487-488

Prevention of diabetes by inhibition of tyrosine phosphatases

(1) Truett, Gary E a

a UNIVERSITY OF TENNESSEE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(MALTOLATO)OXOVANADIUM(IV); INSULIN; INSULIN RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; PYRONE DERIVATIVE; VANADIC ACID;

ADULT; ANIMAL; BODY WEIGHT; CHILD; DRUG ANTAGONISM; EATING; ENZYMOLOGY; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; BODY WEIGHT; CHILD; DIABETES MELLITUS, TYPE 2; EATING; HUMANS; INSULIN; PROTEIN-TYROSINE-PHOSPHATASE; PYRONES; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; VANADATES;

EID: 33745008377 PISSN: 15353702 EISSN: 15353699 Source Type: Journal
DOI: 10.1177/153537020623100501 Document Type: Note

Times cited : (1)

References (7)

1
- 0037223174
- Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
- Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79, 2003.
- (2003) JAMA , vol.289 , pp. 76-79
- Mokdad, A.H.¹ Ford, E.S.² Bowman, B.A.³ Dietz, W.H.⁴ Vinicor, F.⁵ Bales, V.S.⁶ Marks, J.S.⁷

2
- 0141991939
- Lifetime risk for diabetes mellitus in the United States
- Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 290: 1884-1890, 2003.
- (2003) JAMA , vol.290 , pp. 1884-1890
- Narayan, K.M.V.¹ Boyle, J.P.² Thompson, T.J.³ Sorensen, S.W.⁴ Williamson, D.F.⁵

3
- 23944458088
- Pediatric obesity and insulin resistance: Chronic disease risk and implications for treatment and prevention beyond body weight modification
- Cruz ML, Shaibi GQ, Weigensberg MJ, Spruijt-Metz D, Ball GDC, Goran MI. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification. Annu Rev Nutr 25:435-468, 2005.
- (2005) Annu Rev Nutr , vol.25 , pp. 435-468
- Cruz, M.L.¹ Shaibi, G.Q.² Weigensberg, M.J.³ Spruijt-Metz, D.⁴ Ball, G.D.C.⁵ Goran, M.I.⁶

4
- 0037076025
- Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
- Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802-810, 2002.
- (2002) N Engl J Med , vol.346 , pp. 802-810
- Sinha, R.¹ Fisch, G.² Teague, B.³ Tamborlane, W.V.⁴ Banyas, B.⁵ Allen, K.⁶ Savoye, M.⁷ Rieger, V.⁸ Taksali, S.⁹ Barbetta, G.¹⁰ Sherwin, R.S.¹¹ Caprio, S.¹²

5
- 1642473764
- Current therapeutic options in type 2 diabetes mellitus: A practical approach
- Sheehan MT. Current therapeutic options in type 2 diabetes mellitus: a practical approach. Clin Med Res 1:189-200, 2003.
- (2003) Clin Med Res , vol.1 , pp. 189-200
- Sheehan, M.T.¹

6
- 14344255690
- A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato) oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats
- Winter CL, Lange JS, Davis MG, Gerwe GS, Downs TR, Peters KG, Kasibhatla B. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato) oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats. Exp Biol Med (Maywood) 230:207-216, 2005.
- (2005) Exp Biol Med (Maywood) , vol.230 , pp. 207-216
- Winter, C.L.¹ Lange, J.S.² Davis, M.G.³ Gerwe, G.S.⁴ Downs, T.R.⁵ Peters, K.G.⁶ Kasibhatla, B.⁷

7
- 0036470213
- Insulin signaling pathways in time and space
- Saltiel AR, Pessin JE. Insulin signaling pathways in time and space. Trends Cell Biol 12:65-71, 2002.
- (2002) Trends Cell Biol , vol.12 , pp. 65-71
- Saltiel, A.R.¹ Pessin, J.E.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.